Results 131 to 138 of about 1,126 (138)

The societal burden of haemophilia A. III – The potential impact of emicizumab on costs of haemophilia A in Australia

Haemophilia, 2020
Jinjing Li, Laurie J Brown, Hai Anh La
exaly  

Efficacy of emicizumab in a pediatric patient with type 3 von Willebrand disease and alloantibodies

Blood Advances, 2019
Veronica H Flood, Jordan A Shavit, Steven W Pipe   +2 more
exaly  

Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures

Haemophilia, 2020
Leslie Raffini, Christine Guelcher, Janice Kuhn   +2 more
exaly  

Emicizumab use in major orthopedic surgery Free

Blood Advances, 2019
Craig D Seaman
exaly  

Emicizumab for non-severe haemophilia A

The Lancet Haematology, 2023
openaire   +2 more sources

Emicizumab for infants and children with haemophilia A

British Journal of Haematology, 2020
openaire   +2 more sources

Emicizumab prophylaxis among infants and toddlers with severe hemophilia A and inhibitors—a single-center cohort

Pediatric Blood and Cancer, 2019
Tami Livnat, Ivan Budnik, Assaf A Barg
exaly  

Bleeding control improves after switching to emicizumab: Real-world experience of 177 children in the PedNet registry

Haemophilia
Kathelijn Fischer, Jayashree Motwani, Tami Livnat   +2 more
exaly